单次硬膜外注射后深部脊柱感染的发生率与危险因素:380万疼痛门诊患者全国队列研究
该研究利用韩国国民健康保险服务数据库,纳入2009至2018年接受单次门诊硬膜外注射的3,769,014例患者,共12,049,555次注射,识别出2,422例深部脊柱感染(DSI),发生率为0.020%/次注射。多因素分析显示高龄、多种合并症、近期免疫抑制或全身激素使用、90天内≥3次注射及腰骶段注射与DSI风险升高相关,而选择性神经根阻滞与风险降低相关。
要点
- 单次门诊硬膜外注射后DSI发生率为0.020%/次注射,虽罕见但后果严重。
- 高龄、合并症、免疫抑制、90天内多次注射及腰骶段注射增加DSI风险。
- 选择性神经根阻滞与DSI风险降低相关,提示术式选择影响感染风险。
核心结论
- 单次硬膜外注射后DSI虽罕见,但其严重性强调需谨慎选择患者并进行风险分层,尤其对高龄、合并症或免疫抑制患者及腰骶段操作。
研究设计与样本
- 基于韩国国民健康保险服务数据库的全国性队列研究,纳入2009至2018年所有接受单次门诊硬膜外注射的患者,共12,049,555次注射、3,769,014例个体。
- DSI定义为最近一次硬膜外注射后90天内新发感染,需住院并接受至少4周抗生素治疗。
- 采用多因素logistic回归评估患者相关和操作相关危险因素。
主要发现
- 共识别2,422例DSI,发生率为0.020%/次注射。
- 年龄≥65岁(OR 1.04;95% CI 1.04-1.05)、外周血管疾病(OR 1.38;95% CI 1.07-1.78)、慢性肺病(OR 1.33;95% CI 1.11-1.61)、风湿性疾病(OR 1.85;95% CI 1.41-2.43)、消化性溃疡病(OR 1.42;95% CI 1.22-1.66)、肝病(OR 1.57;95% CI 1.34-1.83)、糖尿病(OR 1.44;95% CI 1.14-1.81)、近期使用免疫抑制剂或全身激素(OR 2.44;95% CI 1.73-3.45)、90天内≥3次注射(OR 1.93;95% CI 1.47-2.55)及腰骶段注射(OR 1.70;95% CI 1.45-2.00)与DSI风险升高相关。
- 选择性神经根阻滞与DSI风险降低相关(OR 0.49;95% CI 0.37-0.64)。
临床怎么用
- 对高龄、合并症多、免疫抑制患者及需腰骶段注射者,应加强风险评估与感染预防。
- 避免90天内反复多次硬膜外注射,优先考虑选择性神经根阻滞等风险较低的术式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep spinal infection (DSI) is a rare but potentially devastating complication of epidural injections. This study aimed to determine the nationwide incidence and risk factors of DSI after single-shot outpatient epidural injections for pain management. METHODS: Using customized data from the Korean National Health Insurance Service (Wonju, South Korea) database, all patients who underwent single-shot outpatient epidural injections between 2009 and 2018 were identified. DSI was defined as a new-onset infection within 90 days of the most recent epidural injection that necessitated hospitalization and at least 4 weeks of antibiotic therapy. Multivariable logistic regression was performed to evaluate patient- and procedure-related risk factors. RESULTS: Among 12,049,555 injections in 3,769,014 individuals, 2,422 cases of DSI were identified (0.020% per injection). In multivariable analysis, increased risk was associated with age 65 yr or older (odds ratio [OR], 1.04; 95% CI, 1.04 to 1.05), peripheral vascular disease (OR, 1.38; 95% CI, 1.07 to 1.78), chronic pulmonary disease (OR, 1.33; 95% CI, 1.11 to 1.61), rheumatologic disease (OR, 1.85; 95% CI, 1.41 to 2.43), peptic ulcer disease (OR, 1.42; 95% CI, 1.22 to 1.66), liver disease (OR, 1.57; 95% CI, 1.34 to 1.83), diabetes (OR, 1.44; 95% CI, 1.14 to 1.81), recent immunosuppressant or systemic steroid use (OR, 2.44; 95% CI, 1.73 to 3.45), three or more injections within 90 days (OR, 1.93; 95% CI, 1.47 to 2.55), and lumbosacral-level injections (OR, 1.70; 95% CI, 1.45 to 2.00). In contrast, selective nerve root block was associated with a lower risk of DSI (OR, 0.49; 95% CI, 0.37 to 0.64). CONCLUSION: Although DSI after single-shot epidural injections is rare, its potential severity underscores the importance of careful patient selection and risk stratification, particularly in older patients, those with comorbidities or immunosuppression, and procedures involving the lumbosacral level.
引用
- Nam S, Choi YW, Kang D, et al. Prevalence and Risk Factors of Deep Spinal Infection after Single-shot Epidural Injections: A Nationwide Cohort Study of 3.8 Million Pain Outpatients. Anesthesiology. 2026. PMID: 41944580. doi:10.1097/ALN.0000000000006081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。